358 related articles for article (PubMed ID: 34683334)
21. Gut microbiota metabolites as integral mediators in cardiovascular diseases (Review).
Zhu Y; Shui X; Liang Z; Huang Z; Qi Y; He Y; Chen C; Luo H; Lei W
Int J Mol Med; 2020 Sep; 46(3):936-948. PubMed ID: 32705240
[TBL] [Abstract][Full Text] [Related]
22. Balancing Herbal Medicine and Functional Food for Prevention and Treatment of Cardiometabolic Diseases through Modulating Gut Microbiota.
Lyu M; Wang YF; Fan GW; Wang XY; Xu SY; Zhu Y
Front Microbiol; 2017; 8():2146. PubMed ID: 29167659
[TBL] [Abstract][Full Text] [Related]
23. Role of gut microbiota in cardiovascular diseases.
Novakovic M; Rout A; Kingsley T; Kirchoff R; Singh A; Verma V; Kant R; Chaudhary R
World J Cardiol; 2020 Apr; 12(4):110-122. PubMed ID: 32431782
[TBL] [Abstract][Full Text] [Related]
24. Gut Microbiota and Cardiovascular System: An Intricate Balance of Health and the Diseased State.
Bhat MA; Mishra AK; Tantray JA; Alatawi HA; Saeed M; Rahman S; Jan AT
Life (Basel); 2022 Nov; 12(12):. PubMed ID: 36556351
[TBL] [Abstract][Full Text] [Related]
25. The gut microbiota and its interactions with cardiovascular disease.
Xu H; Wang X; Feng W; Liu Q; Zhou S; Liu Q; Cai L
Microb Biotechnol; 2020 May; 13(3):637-656. PubMed ID: 31984651
[TBL] [Abstract][Full Text] [Related]
26. Role of Gut Microbiota and Their Metabolites on Atherosclerosis, Hypertension and Human Blood Platelet Function: A Review.
Duttaroy AK
Nutrients; 2021 Jan; 13(1):. PubMed ID: 33401598
[TBL] [Abstract][Full Text] [Related]
27. Novel insights in the relationship of gut microbiota and coronary artery diseases.
Ramírez-Macías I; Orenes-Piñero E; Camelo-Castillo A; Rivera-Caravaca JM; López-García C; Marín F
Crit Rev Food Sci Nutr; 2022; 62(14):3738-3750. PubMed ID: 33399007
[TBL] [Abstract][Full Text] [Related]
28. Dysbiosis is one of the risk factor for stroke and cognitive impairment and potential target for treatment.
Koszewicz M; Jaroch J; Brzecka A; Ejma M; Budrewicz S; Mikhaleva LM; Muresanu C; Schield P; Somasundaram SG; Kirkland CE; Avila-Rodriguez M; Aliev G
Pharmacol Res; 2021 Feb; 164():105277. PubMed ID: 33166735
[TBL] [Abstract][Full Text] [Related]
29. The Role of Gut Microbiota in Atherosclerosis and Hypertension.
Ma J; Li H
Front Pharmacol; 2018; 9():1082. PubMed ID: 30319417
[TBL] [Abstract][Full Text] [Related]
30. Gut Microbiota and Cardiovascular Disease: Symbiosis Versus Dysbiosis.
Manolis AA; Manolis TA; Melita H; Manolis AS
Curr Med Chem; 2022; 29(23):4050-4077. PubMed ID: 34961453
[TBL] [Abstract][Full Text] [Related]
31. Importance of gut microbiota metabolites in the development of cardiovascular diseases (CVD).
Hemmati M; Kashanipoor S; Mazaheri P; Alibabaei F; Babaeizad A; Asli S; Mohammadi S; Gorgin AH; Ghods K; Yousefi B; Eslami M
Life Sci; 2023 Sep; 329():121947. PubMed ID: 37463653
[TBL] [Abstract][Full Text] [Related]
32. Two Gut Microbiota-Derived Toxins Are Closely Associated with Cardiovascular Diseases: A Review.
Yamashita T; Yoshida N; Emoto T; Saito Y; Hirata KI
Toxins (Basel); 2021 Apr; 13(5):. PubMed ID: 33921975
[TBL] [Abstract][Full Text] [Related]
33. Gut Dysbiosis and Immune System in Atherosclerotic Cardiovascular Disease (ACVD).
Yoo JY; Sniffen S; McGill Percy KC; Pallaval VB; Chidipi B
Microorganisms; 2022 Jan; 10(1):. PubMed ID: 35056557
[TBL] [Abstract][Full Text] [Related]
34. Cardiovascular Diseases of Developmental Origins: Preventive Aspects of Gut Microbiota-Targeted Therapy.
Hsu CN; Hou CY; Hsu WH; Tain YL
Nutrients; 2021 Jul; 13(7):. PubMed ID: 34371800
[TBL] [Abstract][Full Text] [Related]
35. Pleiotropic activities of succinate: The interplay between gut microbiota and cardiovascular diseases.
Xu J; Yang Y; Li X; Ding S; Zheng L; Xiong C; Yang Y
Imeta; 2023 Aug; 2(3):e124. PubMed ID: 38867936
[TBL] [Abstract][Full Text] [Related]
36. Gut microbiota interactions with anti-diabetic medications and pathogenesis of type 2 diabetes mellitus.
Kant R; Chandra L; Verma V; Nain P; Bello D; Patel S; Ala S; Chandra R; Antony MA
World J Methodol; 2022 Jul; 12(4):246-257. PubMed ID: 36159100
[TBL] [Abstract][Full Text] [Related]
37. Current understanding of gut microbiota alterations and related therapeutic intervention strategies in heart failure.
Chen X; Li HY; Hu XM; Zhang Y; Zhang SY
Chin Med J (Engl); 2019 Aug; 132(15):1843-1855. PubMed ID: 31306229
[TBL] [Abstract][Full Text] [Related]
38. Implication of Gut Microbiota in Cardiovascular Diseases.
Zhou W; Cheng Y; Zhu P; Nasser MI; Zhang X; Zhao M
Oxid Med Cell Longev; 2020; 2020():5394096. PubMed ID: 33062141
[TBL] [Abstract][Full Text] [Related]
39. Gut-Lung Axis in Focus: Deciphering the Impact of Gut Microbiota on Pulmonary Arterial Hypertension.
Suswał K; Tomaszewski M; Romaniuk A; Świechowska-Starek P; Zygmunt W; Styczeń A; Romaniuk-Suswał M
J Pers Med; 2023 Dec; 14(1):. PubMed ID: 38276223
[TBL] [Abstract][Full Text] [Related]
40. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
Halmos T; Suba I
Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
